Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MintNeuro is developing a platform of ultra-miniaturized, low-power bioelectronic implants based on proprietary semiconductor technology. The company’s chips are designed to be over 100 times smaller than current state-of-the-art devices and can wirelessly sense or modulate neural activity. Early-stage collaborations target epilepsy monitoring and neuromodulation for conditions like urinary incontinence. Clinical results are not yet published; the company is currently focused on preclinical development and validation with academic partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MintNeuro.